OA10986A - Crystalline pharmaceutical product - Google Patents

Crystalline pharmaceutical product Download PDF

Info

Publication number
OA10986A
OA10986A OA9900047A OA9900047A OA10986A OA 10986 A OA10986 A OA 10986A OA 9900047 A OA9900047 A OA 9900047A OA 9900047 A OA9900047 A OA 9900047A OA 10986 A OA10986 A OA 10986A
Authority
OA
OAPI
Prior art keywords
tetrahydro
oxo
hydrochloride
benzodiazepine
carbonyl
Prior art date
Application number
OA9900047A
Other languages
English (en)
Inventor
Stephen Torey Ross
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of OA10986A publication Critical patent/OA10986A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
OA9900047A 1996-09-03 1999-03-03 Crystalline pharmaceutical product OA10986A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2536996P 1996-09-03 1996-09-03

Publications (1)

Publication Number Publication Date
OA10986A true OA10986A (en) 2003-03-04

Family

ID=21825633

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9900047A OA10986A (en) 1996-09-03 1999-03-03 Crystalline pharmaceutical product

Country Status (32)

Country Link
US (1) US6335330B1 (de)
EP (1) EP0964684B1 (de)
JP (1) JP2000517342A (de)
CN (1) CN1102391C (de)
AP (1) AP9901472A0 (de)
AR (1) AR008154A1 (de)
AT (1) ATE245984T1 (de)
AU (1) AU731173B2 (de)
BG (1) BG103196A (de)
BR (1) BR9711981A (de)
CA (1) CA2264607A1 (de)
CO (1) CO4930262A1 (de)
CZ (1) CZ71999A3 (de)
DE (1) DE69723873T2 (de)
DZ (1) DZ2302A1 (de)
EA (1) EA001363B1 (de)
ES (1) ES2205254T3 (de)
HU (1) HUP9904077A3 (de)
ID (1) ID18156A (de)
IL (1) IL128782A0 (de)
MA (1) MA24309A1 (de)
MY (1) MY118175A (de)
NO (1) NO991013L (de)
NZ (1) NZ334438A (de)
OA (1) OA10986A (de)
PE (1) PE107198A1 (de)
PL (1) PL332006A1 (de)
SK (1) SK27699A3 (de)
TR (1) TR199900480T2 (de)
UY (1) UY24690A1 (de)
WO (1) WO1998009629A1 (de)
ZA (1) ZA977870B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19902529A1 (de) * 1999-01-22 2000-08-03 Goldwell Gmbh Haarbehandlungsmittel
FR2797400A1 (fr) * 1999-08-11 2001-02-16 Sanofi Synthelabo Associations a activite anti-thrombotique constituees de l'hydrogenosulfate de clopidogrel et d'un antagoniste des recepteurs gpiib/iiia et les compositions pharmaceutiques les contenant
KR20040058229A (ko) 2001-10-22 2004-07-03 더 스크립스 리서치 인스티튜트 항체 표적화 화합물
US20050202151A1 (en) * 2004-03-15 2005-09-15 Land O'lakes, Inc. Method of preparing egg nuggets
KR101046977B1 (ko) * 2004-11-15 2011-07-07 삼성에스디아이 주식회사 카본나노튜브, 이를 포함한 전자 방출원 및 이를 구비한전자 방출 소자
US20070122408A1 (en) * 2005-10-20 2007-05-31 The Scripps Research Institute Fc Labeling for Immunostaining and Immunotargeting
US8518927B2 (en) 2009-02-10 2013-08-27 The Scripps Research Institute Chemically programmed vaccination

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD138319A1 (de) * 1978-08-08 1979-10-24 Helmut Roehnert Verfahren zur herstellung einer stabilen,kristallwasser-und kristalloesungsmittelfreien kristallform des 7-chlor-2-methylamino-5-phenyl-3h-1,4-benzodiazepin-4-oxid-hydrochlorids
EP0593603B1 (de) 1991-06-28 2002-11-20 Smithkline Beecham Corporation Bizyklische fibrinogenantagonisten
US5939412A (en) 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
NZ259802A (en) 1992-12-21 1997-10-24 Smithkline Beecham Corp Bicyclic derivatives and pharmaceutical compositions
MA23420A1 (fr) * 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.

Also Published As

Publication number Publication date
EP0964684A4 (de) 2002-05-29
ATE245984T1 (de) 2003-08-15
US6335330B1 (en) 2002-01-01
AR008154A1 (es) 1999-12-09
ES2205254T3 (es) 2004-05-01
EP0964684A1 (de) 1999-12-22
SK27699A3 (en) 2000-02-14
AU4242597A (en) 1998-03-26
HUP9904077A2 (hu) 2000-05-28
NO991013D0 (no) 1999-03-02
EP0964684B1 (de) 2003-07-30
DZ2302A1 (fr) 2002-12-28
CA2264607A1 (en) 1998-03-12
ID18156A (id) 1998-03-05
IL128782A0 (en) 2000-01-31
DE69723873D1 (de) 2003-09-04
MA24309A1 (fr) 1998-04-01
CO4930262A1 (es) 2000-06-27
CN1234739A (zh) 1999-11-10
AP9901472A0 (en) 1999-03-31
PE107198A1 (es) 1999-03-21
JP2000517342A (ja) 2000-12-26
BG103196A (en) 1999-09-30
HUP9904077A3 (en) 2002-03-28
DE69723873T2 (de) 2004-04-22
NO991013L (no) 1999-03-02
WO1998009629A1 (en) 1998-03-12
TR199900480T2 (xx) 1999-06-21
CN1102391C (zh) 2003-03-05
NZ334438A (en) 2000-10-27
ZA977870B (en) 1998-03-03
AU731173B2 (en) 2001-03-22
PL332006A1 (en) 1999-08-16
EA199900260A1 (ru) 1999-08-26
BR9711981A (pt) 1999-08-24
CZ71999A3 (cs) 1999-08-11
UY24690A1 (es) 1998-02-27
EA001363B1 (ru) 2001-02-26
MY118175A (en) 2004-09-30

Similar Documents

Publication Publication Date Title
CA2627086C (en) Novel pharmaceutical salts and polymorphs of a factor xa inhibitor
CA2810004C (en) Crystalline forms of a factor xa inhibitor
HUT74103A (en) Aroyl-piperidine derivative
EP0964684B1 (de) Kristallines pharmazeutisches produkt
JPH03141221A (ja) トランスグルタミナーゼ阻害剤としての一定のイミダゾール化合物類
CN101516833A (zh) 用作凝血因子IXa抑制剂的酒石酸衍生物
PT770082E (pt) Derivados de acido dioxo-tiopirano-piridinocarboxilico e sua utilizacao como medicamentos
JP2000512648A (ja) ピペリジン酢酸誘導体および血栓障害の治療におけるそれらの使用
WO2019001307A1 (zh) 一种酰胺类化合物及包含该化合物的组合物及其用途
KR20140022851A (ko) 오타믹사반의 벤조산염
MXPA99002118A (en) Crystalline pharmaceutical product
KR20000068406A (ko) 결정질 제약 물질
JPH03118371A (ja) イミダゾール化合物及びトランスグルタミナーゼ阻害剤としてのその使用
SG190072A1 (en) Organic amine salts of aminobenzoic acid derivatives and method for producing same
HK1186181B (en) Crystalline forms of a factor xa inhibitor